23 Jul, 2026
According to Straits Research, the global smart pills market size was valued at $2.57 billion in 2025 and is projected to grow from $2.85 billion in 2026 to $6.76 billion by 2034, registering a CAGR of 11.38% during the forecast period 2026–2034.
The market growth is primarily attributed to the increasing prevalence of chronic conditions, such as colon cancer is driving the demand for advanced diagnostic tools. For example, in July 2024, as per the data reported in the National Library of Medicine, the PillCam COLON 2 system, developed by Medtronic, is a smart pill designed for colon cancer screening. This ingestible capsule contains a small camera that captures images of the colon as it travels through the gastrointestinal tract. Such a factor highlights the growing importance of smart pills in modern healthcare and their potential to transform disease management strategies. The high cost of devices and procedures, which limits adoption, especially in developing regions, limits the market growth. The advanced imaging technology, embedded sensors, and data analysis systems significantly increase overall costs, making smart pills less accessible for patients and healthcare facilities with constrained budgets. Moreover, the incorporation of AI into smart pill technologies presents a significant market opportunity by enabling advanced data analytics, personalized treatment, and predictive diagnostics. For example, in January 2025, Proteus Digital Health announced the launch of its AI-enabled smart pill platform that monitors patient medication adherence and predicts potential complications in real time. Such innovation highlights the potential of AI integration to enhance patient outcomes and drive wider adoption of smart pill technologies.
sales@straitsresearch.com